Literature DB >> 6431863

Treatable meningeal involvement in Waldenström's macroglobulinemia.

J J Torrey, S B Katakkar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431863     DOI: 10.7326/0003-4819-101-3-345

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

Review 2.  Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literature.

Authors:  Roneil G Malkani; Martin Tallman; Numa Gottardi-Littell; William Karpus; Laura Marszalek; Daina Variakojis; Bruce Kaden; Matthew Walker; Robert M Levy; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2009-07-18       Impact factor: 4.130

3.  Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapy.

Authors:  Bernardo Liberato; Adrienne Riethmuller; Raymond L Comenzo; Eric Lis; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

4.  Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.

Authors:  Hyun Do Kim; Kyeong Cheol Shin; Hee Soon Cho; Min Kyoung Kim; Kyung Hee Lee; Myung Soo Hyun
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.